开云app官网登录入口网页版-官方正版

#GVHD#

2篇内容 | 1644人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2222853, encodeId=f3f42222853e6, content=<a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> <a href='/topic/show?id=b7e449e676e' target=_blank style='color:#2F92EE;'>#异基因造血细胞移植#</a> <a href='/topic/show?id=f5bc52353ce' target=_blank style='color:#2F92EE;'>#急性移植物抗宿主病#</a>, objectTitle=【Nature子刊】综述：急性移植物抗宿主病, objectType=article, longId=840866, objectId=da94840866a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240821/1724206335771_8538692.jpg, objectUrl=/article/show_article.do?id=da94840866a4, replyNumber=0, likeNumber=37, createdTime=2024-08-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=da94840866a4, moduleTitle=【Nature子刊】综述：急性移植物抗宿主病, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=da94840866a4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210228, encodeId=5d87221022807, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> <a href='/topic/show?id=62e7115581a6' target=_blank style='color:#2F92EE;'>#非亲缘移植#</a>, objectTitle=【AJH】AML非亲缘移植，PTCy与传统GVHD预防的复发率无差异, objectType=article, longId=830351, objectId=87c483035125, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240616/1718550177829_5579292.jpg, objectUrl=/article/show_article.do?id=87c483035125, replyNumber=0, likeNumber=72, createdTime=2024-06-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=87c483035125, moduleTitle=【AJH】AML非亲缘移植，PTCy与传统GVHD预防的复发率无差异, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=87c483035125)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201740, encodeId=b1722201e40f2, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=a798e520582' target=_blank style='color:#2F92EE;'>#移植物抗宿主病#</a> <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> <a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, objectTitle=【BMC Med】微小剂量甲氨蝶呤联合甲泼尼龙用于急性GVHD初始治疗的3期研究, objectType=article, longId=824253, objectId=1d62824253e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=1d62824253e5, replyNumber=0, likeNumber=85, createdTime=2024-05-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1d62824253e5, moduleTitle=【BMC Med】微小剂量甲氨蝶呤联合甲泼尼龙用于急性GVHD初始治疗的3期研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1d62824253e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199616, encodeId=0cbd2199616cb, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=a798e520582' target=_blank style='color:#2F92EE;'>#移植物抗宿主病#</a> <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a>, objectTitle=【BMT】PTCy/CNI/MMF对比ATG/CNI/MTX用于AML移植后预防GVHD无显著差异, objectType=article, longId=822628, objectId=720382262867, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-staff-meeting-GXNVP9J.jpg, objectUrl=/article/show_article.do?id=720382262867, replyNumber=0, likeNumber=103, createdTime=2024-04-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=720382262867, moduleTitle=【BMT】PTCy/CNI/MMF对比ATG/CNI/MTX用于AML移植后预防GVHD无显著差异, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=720382262867)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182719, encodeId=952f2182e1903, content=<a href='/topic/show?id=a798e520582' target=_blank style='color:#2F92EE;'>#移植物抗宿主病#</a> <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> <a href='/topic/show?id=3146892e7c7' target=_blank style='color:#2F92EE;'>#血液恶性肿瘤#</a>, objectTitle=【Lancet Haematol】EBMT关于血液恶性肿瘤移植后GVHD预防与治疗的指南更新, objectType=article, longId=810030, objectId=4f71810030e1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=4f71810030e1, replyNumber=0, likeNumber=91, createdTime=2024-01-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=4f71810030e1, moduleTitle=【Lancet Haematol】EBMT关于血液恶性肿瘤移植后GVHD预防与治疗的指南更新, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4f71810030e1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2092794, encodeId=46e92092e949f, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a><a href='/topic/show?id=11fd2565952' target=_blank style='color:#2F92EE;'>#伊布替尼#</a>用于儿童慢性 <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> 患者。<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>每年要批准大量的<a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#创新药物#</a>，非常值得关注, objectTitle=FDA 批准伊布替尼用于儿童慢性 GVHD 患者, objectType=article, longId=736912, objectId=3174e369127e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220824/1661347590610_5579292.jpg, objectUrl=/article/show_article.do?id=3174e369127e, replyNumber=0, likeNumber=141, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3174e369127e, moduleTitle=FDA 批准伊布替尼用于儿童慢性 GVHD 患者, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3174e369127e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=888801, encodeId=e6d58888011a, content=<a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a>, objectTitle=Blood：采用IRX4204靶向维甲酸核受体可预防急性GVHD, objectType=article, longId=201308, objectId=b382201308f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020927/1601188482624_2110107.PNG, objectUrl=/article/show_article.do?id=b382201308f4, replyNumber=0, likeNumber=136, createdTime=2020-09-27, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b382201308f4, moduleTitle=Blood：采用IRX4204靶向维甲酸核受体可预防急性GVHD, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b382201308f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

GVHD

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#GVHD# #异基因造血细胞移植# #急性移植物抗宿主病#

【Nature子刊】综述：急性移植物抗宿主病

2024-08-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #GVHD# #非亲缘移植#

【AJH】AML非亲缘移植，PTCy与传统GVHD预防的复发率无差异

2024-06-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #移植物抗宿主病# #GVHD# #甲泼尼龙#

【BMC Med】微小剂量甲氨蝶呤联合甲泼尼龙用于急性GVHD初始治疗的3期研究

2024-05-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#AML# #移植物抗宿主病# #GVHD#

【BMT】PTCy/CNI/MMF对比ATG/CNI/MTX用于AML移植后预防GVHD无显著差异

2024-04-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#移植物抗宿主病# #GVHD# #血液恶性肿瘤#

【Lancet Haematol】EBMT关于血液恶性肿瘤移植后GVHD预防与治疗的指南更新

2024-01-19发表于陕西省

lifestar (审核中...)

前往app查看评论内容

#FDA批准##伊布替尼#用于儿童慢性 #GVHD# 患者。#FDA#每年要批准大量的#创新药物#，非常值得关注

FDA 批准伊布替尼用于儿童慢性 GVHD 患者

2022-10-10

Nebula-Qin (审核中...)

前往app查看评论内容

#GVHD#

Blood：采用IRX4204靶向维甲酸核受体可预防急性GVHD

2020-09-27

科室
- - 订阅+
  - 更多科室
工具
服务